Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties

Recent studies have demonstrated that ivermectin (IVM) exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of coronavirus disease 2019 (COVID-19). However, the repurposing of IVM for the treatment of COVID-19 has presented challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jinpeng, Lu, Caihong, Ding, Yaning, Zhang, Jinbang, Tan, Fangyun, Liu, Jingzhou, Yang, Guobao, Wang, Yuli, Li, Zhiping, Yang, Meiyan, Yang, Yang, Gong, Wei, Gao, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978457/
https://www.ncbi.nlm.nih.gov/pubmed/35390488
http://dx.doi.org/10.1016/j.ijpharm.2022.121719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978457/
https://www.ncbi.nlm.nih.gov/pubmed/35390488
http://dx.doi.org/10.1016/j.ijpharm.2022.121719

Ejemplares similares